<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03502863</url>
  </required_header>
  <id_info>
    <org_study_id>OPT-1001</org_study_id>
    <nct_id>NCT03502863</nct_id>
  </id_info>
  <brief_title>Clinical Study to Evaluate Effectiveness of Opternative Vision Test</brief_title>
  <official_title>A Prospective Clinical Study to Evaluate the Effectiveness of Opternative Vision Test</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Opternative</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Opternative</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, comparative, randomized, non-masked clinical study to compare the Opternative
      Vision Test with LogMAR VA testing utilizing trial lenses, to standard manual refraction
      using a Phoropter, and LogMAR VA testing, in accuracy of visual acuity measurement.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Opternative Vision Test is used as a digital self-administered device to measure visual
      acuity and to subjectively measure refractive value for a patient's eye for the conditions of
      myopia and astigmatism. The Opternative Vision Test is intended for adults aged 22 to 55
      years that have no prior correction with up to 3.00 diopters (D) of myopia and up to 2.00 D
      of astigmatism, or those with prior correction up to 10.00 D of myopia and require an
      over-refraction of no more than 2.75 D.

      LogMAR (ETDRS) chart to measure visual acuity.

      The manual manifest refraction is performed by an eyecare specialist using a phoropter.

      The LogMAR Visual Acuity chart is used to measure visual acuity. The manual refraction will
      be used in this study for obtaining the refractive error of each eye.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2018</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opternative Vision Test will be compared to standard manual refraction methods (using a phoropter) to the correlation of the two methods.</measure>
    <time_frame>After the Day 1 Visits</time_frame>
    <description>The difference between testing methods (Manual Refraction with a phoropter versus Opternative Vision Test) will be analyzed by mean, standard deviation, and 95% confidence interval overall and by the levels of refractive correction (sphere, cylinder, MRSE) and for visual acuity using LogMAR format.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Myopia</condition>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>Opternative</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Manual Refraction</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Opternative</intervention_name>
    <description>Opternative Vision Test, a web-based application for obtaining the refractive error and visual acuity of each eye, using a computer and a smartphone.</description>
    <arm_group_label>Manual Refraction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Manual Refraction</intervention_name>
    <description>Manual refraction and ETDRS chart</description>
    <arm_group_label>Opternative</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject must be between 22 and 55 years of age at the time of consent.

          2. Subject must have a refractive error

               1. With no greater than -3.00 D myopia and -2.00 D astigmatism in either eye.

               2. With prior correction of no greater than -10.00 D myopia and requiring
                  over-refraction of no more than 2.75 D in either eye.

        5. Subjects with BCVA of 20/32 or better.

        Exclusion Criteria:

          1. Subjects with diabetes mellitus.

          2. Subjects using ophthalmic or systemic corticosteroids.

          3. Subjects with autoimmune conditions.

          4. Subjects with active corneal or conjunctival infection.

          5. Subjects with active corneal, conjunctival, or intraocular inflammation (ie, uveitis).

          6. Subjects with diabetic retinopathy.

          7. Subjects with glaucoma or ocular hypertension.

          8. Subjects with macular degeneration.

          9. Subjects with previous ocular surgery.

         10. Subjects on antihyperglycemic agents; corticosteroids; hydroxychloroquine (Plaquenil)
             and chloroquine (Aralen); tamoxifen (Nolvadex).

         11. Pregnancy

         12. Subjects who, in the judgment of the Investigator, may be inappropriate for the
             intended study procedures.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Lee</last_name>
    <role>Study Director</role>
    <affiliation>Chief Science Officer</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Steven Lee</last_name>
    <phone>3122834560</phone>
    <email>Steven@opternative.com</email>
  </overall_contact>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2018</study_first_submitted>
  <study_first_submitted_qc>April 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2018</study_first_posted>
  <last_update_submitted>April 17, 2018</last_update_submitted>
  <last_update_submitted_qc>April 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

